{"id":"https://openalex.org/W2247147336","doi":"https://doi.org/10.1007/s00520-015-2712-y","title":"Is metronomic chemotherapy less toxic than conventional chemotherapy in the randomized phase 2 XeNa trial combining navelbine oral and Xeloda for HER2 negative breast cancer patients","display_name":"Is metronomic chemotherapy less toxic than conventional chemotherapy in the randomized phase 2 XeNa trial combining navelbine oral and Xeloda for HER2 negative breast cancer patients","publication_year":2015,"publication_date":"2015-01-01","ids":{"openalex":"https://openalex.org/W2247147336","doi":"https://doi.org/10.1007/s00520-015-2712-y","mag":"2247147336"},"language":"en","primary_location":{"id":"mag:2247147336","doi":null,"is_oa":true,"landing_page_url":"https://repository.urosario.edu.co/handle/10336/26496","pdf_url":null,"source":{"id":"https://openalex.org/S4306401708","display_name":"Repositorio Institucional E-DocUR (Universidad Del Rosario)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I90803817","host_organization_name":"Universidad del Rosario","host_organization_lineage":["https://openalex.org/I90803817"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Repositorio Institucional E-DocUR (Universidad Del Rosario)","raw_type":null},"volume":null,"type":"article","is_traditional":true,"indexed_in":[],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://repository.urosario.edu.co/handle/10336/26496","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5022833152","display_name":"Anne Sofie Brems-Eskildsen","orcid":"https://orcid.org/0000-0002-8104-5950","observed_orcids":["https://orcid.org/0000-0002-8104-5950"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Anne Sofie Brems-Eskildsen","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5049574284","display_name":"Soeren Linnet","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Soeren Linnet","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5003804657","display_name":"Adam Andrzej Luczak","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Adam Andrzej Luczak","raw_affiliation_strings":["Det Sundhedsvidenskabelige Fakultet"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Det Sundhedsvidenskabelige Fakultet","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5057103815","display_name":"Henrik Anker Nielsen","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Henrik Anker Nielsen","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5054818988","display_name":"Peter Michael Vestlev","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Peter Michael Vestlev","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5083259679","display_name":"Brita Bjerregaard Jensen","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Brita B. Jensen","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5005826375","display_name":"T. Hilling","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"T. Hilling","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5037981989","display_name":"Trine Dongsgaard","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Trine Dongsgaard","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110621344","display_name":"C. B. Jensen","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"C. B. Jensen","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5034528968","display_name":"Jeppe Neimann","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"J. Neimann","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5024027991","display_name":"Ann\u2010Britt Nygaard","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ann\u2010Britt Nygaard","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5035537863","display_name":"Sven Tyge Langkjer","orcid":"https://orcid.org/0000-0002-5047-7523","observed_orcids":["https://orcid.org/0000-0002-5047-7523"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Sven Tyge Langkjer","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-5047-7523","affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.1036,"has_fulltext":false,"cited_by_count":1,"citation_normalized_percentile":{"value":0.47226055,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":93},"biblio":{"volume":"23","issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10183","display_name":"Breast Cancer Treatment Studies","score":0.5752000212669373,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10183","display_name":"Breast Cancer Treatment Studies","score":0.5752000212669373,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11752","display_name":"Cancer Treatment and Pharmacology","score":0.3822999894618988,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10755","display_name":"HER2/EGFR in Cancer Research","score":0.015699999406933784,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/metronomic-chemotherapy","display_name":"metronomic chemotherapy","score":0.9990000128746033},{"id":"https://openalex.org/keywords/vinorelbine","display_name":"vinorelbine","score":0.746999979019165},{"id":"https://openalex.org/keywords/capecitabine","display_name":"capecitabine","score":0.9039999842643738},{"id":"https://openalex.org/keywords/her2-negative-breast-cancer","display_name":"HER2-negative breast cancer","score":0.9539999961853027},{"id":"https://openalex.org/keywords/chemotherapy-toxicity","display_name":"chemotherapy toxicity","score":0.8080000281333923},{"id":"https://openalex.org/keywords/oral-chemotherapy","display_name":"oral chemotherapy","score":0.753000020980835}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.912439227104187},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.634526252746582},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.630198061466217},{"id":"https://openalex.org/C2781190966","wikidata":"https://www.wikidata.org/wiki/Q420436","display_name":"Docetaxel","level":3,"score":0.5649464726448059},{"id":"https://openalex.org/C168563851","wikidata":"https://www.wikidata.org/wiki/Q1436668","display_name":"Randomized controlled trial","level":2,"score":0.5440461039543152},{"id":"https://openalex.org/C530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","level":3,"score":0.5266948938369751},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5177266001701355},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.38569796085357666}],"mesh":[],"locations_count":2,"locations":[{"id":"mag:2247147336","doi":null,"is_oa":true,"landing_page_url":"https://repository.urosario.edu.co/handle/10336/26496","pdf_url":null,"source":{"id":"https://openalex.org/S4306401708","display_name":"Repositorio Institucional E-DocUR (Universidad Del Rosario)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I90803817","host_organization_name":"Universidad del Rosario","host_organization_lineage":["https://openalex.org/I90803817"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Repositorio Institucional E-DocUR (Universidad Del Rosario)","raw_type":null},{"id":"pmh:oai:pure.atira.dk:publications/1a76ba33-5154-4718-bb0f-51a118918ae5","doi":"https://doi.org/10.1007/s00520-015-2712-y","is_oa":false,"landing_page_url":"https://vbn.aau.dk/da/publications/1a76ba33-5154-4718-bb0f-51a118918ae5","pdf_url":null,"source":{"id":"https://openalex.org/S4306401731","display_name":"VBN Forskningsportal (Aalborg Universitet)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I891191580","host_organization_name":"Aalborg University","host_organization_lineage":["https://openalex.org/I891191580"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Brems-Eskildsen, A S, Linnet, S, Luczak, A A, Nielsen, H A, Vestlev, P M, Jensen, B B, Hilling, T, Dongsgaard, T, Jensen, C B, Neimann, J, Nygaard, A B & Langkjer, S T 2015, 'Is metronomic chemotherapy less toxic than conventional chemotherapy in the randomized phase 2 XeNa trial combining navelbine oral and Xeloda for HER2 negative breast cancer patients?', Supportive Care in Cancer, vol. 23, no. Suppl 1, 26-017-P, pp. S353. https://doi.org/10.1007/s00520-015-2712-y","raw_type":"info:eu-repo/semantics/publishedVersion"}],"best_oa_location":{"id":"mag:2247147336","doi":null,"is_oa":true,"landing_page_url":"https://repository.urosario.edu.co/handle/10336/26496","pdf_url":null,"source":{"id":"https://openalex.org/S4306401708","display_name":"Repositorio Institucional E-DocUR (Universidad Del Rosario)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I90803817","host_organization_name":"Universidad del Rosario","host_organization_lineage":["https://openalex.org/I90803817"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Repositorio Institucional E-DocUR (Universidad Del Rosario)","raw_type":null},"sustainable_development_goals":[{"score":0.9537000060081482,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W3109199934","https://openalex.org/W2964752191","https://openalex.org/W4220961927","https://openalex.org/W2399296753","https://openalex.org/W2898573106","https://openalex.org/W2986894558","https://openalex.org/W2950728748","https://openalex.org/W4205569559","https://openalex.org/W4412198499","https://openalex.org/W2366585808"],"abstract_inverted_index":null,"counts_by_year":[{"year":2016,"cited_by_count":1}],"updated_date":"2026-10-12T09:40:04.860316","created_date":"2016-06-24T00:00:00"}